Previously as an executive at Motorola, Dr. Anantha lead a global team that created several award winning enterprise wireless products and brought them to market worldwide. As VP Engineering at Wireless Valley (a startup acquired by Motorola), he lead a team that invented wireless technologies that are used around the world today to design and manage complex wireless networks (most wireless routers in buildings and campuses work well today because to this ubiquitous technology). While at Intrinsity (a startup acquired by Apple), Dr. Anantha worked with a team that built the world’s fastest Digital Signal Processor at the time.
Adam Atherly is Professor in the Department of Health Systems, Management and Policy in the Colorado School of Public Health at the University of Colorado. Dr. Atherly’s main area of research is health economics, with an emphasis on the economics of aging and consumer decisions regarding health plan choice and health. Dr. Atherly has studied the effect of health on health care spending, including studies examining the effect of Dementia of the Alzheimer’s Type on Medicare spending; lifetime spending and life expectancy projections for Medicare beneficiaries with and without chronic illnesses; the effect of copayments and other cost sharing on health care spending. Dr. Atherly also has experience in health outcomes research includes scale development, evaluation of efforts to improve quality of care and patient safety and cost effectiveness analysis.
Regina has published numerous articles on market and technology trends such as "Immuno-oncology: Can the Right Chimeric Antigen Receptors T-Cell Design be Made to Cure All Types of Cancers and Will it be Covered?" in the Journal of Pharmaceutics, "Why Our Microbiome is Important to Our Physiology and Diseases" in the International Journal of Clinical Pharmacology and Pharmacotherapy, "From Genetic Engineering to Genome Engineering: What Impact Has it Made on Science and Society?" in Advances in Biology, Biotechnology and Genetics, and "The paradigm shift to an “open” model in drug development" in Applied and Translational Genomics. Her expertise is in a number therapeutic areas such as cardiology, interventional cardiology, infectious disease, immunology, gastroenterology, neurology, oncology and surgery. Prior to BioMarketing Insight she worked for Merck & Co., Genzyme Corp., NMT Medical, and Radi Medical (St. Jude Medical) in various positions of increasing responsibility in new product planning, marketing and sales. She had P&L responsibility in managing six multimillion dollar product lines and has experience in upstream and downstream marketing including strategic marketing, product development, market development, product launches, and product management.
Dr. Carmody is the Cybersecurity Program Manager for the Center for Devices and Radiological Health, serving as co-chair of CDRH's Cybersecurity Working Group. The Cybersecurity Working Group is an interdisciplinary team responsible for the FDA's final pre- and post-market cybersecutiry guidances. Seth joined CDRH in 2011 as a medical device reviewer.
With 25+ years of experience in health insurance and financial technology, Lynn is known as a creative leader and innovator in healthcare reimbursement strategy and electronic payments. With the increasing focus on value-based payments, consumer engagement, and alternative payment models, Lynn is leading HealthshareBlox’s design of blockchain solutions for the healthcare ecosystem. Lynn is a graduate of the University of Illinois.
Robert Denson is the Chief Information Officer, as well as the HIPAA Compliance Officer for the Colorado Regional Health Information Organization(CORHIO). As the CIO, Robert and his team provide implementation and support of the Health Information Exchange. Robert’s team also includes Product Development and Innovation, which investigates and builds new Health Information Exchange capabilities to meet the ever expanding needs of the Community. As the Compliance Officer of CORHIO, Robert ensures the safety and protection of the sensitive patient information (PHI) that is stored, processed or transmitted by CORHIO. Prior to CORHIO, Robert worked for Avaya and has over ten years of management experience within multiple support environments and industries. He is also a Board Member for the Arapahoe Community College Health Information Technology Program.
Bill Fox, J.D.,M.A, is the Global CTO for Insurance, Healthcare and Life Sciences at Marklogic. He is a nationally recognized author and speaker on the use of big data and analytics in healthcare and insurance. He is the former Deputy Chief of Economic and Cyber Crime at the Philadelphia District Attorney’s office and Special Assistant U.S.Attorney. He has helped the country’s largest insurance companies, Government agencies, healthcare payers, and pharmas to operationalize and understand their data to deliver better services and products to their consumers and drive competitive advantage.
Karl Hess, M.B.A., B.A., P.M.P., is currently Senior Vice President of Population Health at Collain Healthcare, LLC., an LG CNS subsidiary, where he is responsible for LG CNS' portfolio of digital health products and services, which is purposed to enable the future of actual population health management and value-based care for frail and vulnerable populations. Prior to rejoining Collain Healthcare, Karl was a Founding Managing Director of OnDigitalHealth Consulting, LLC, a specialized strategy consulting firm which he founded to serve the burgeoning and rapidly diversifying digital health industry. As Managing Director, Karl served as chief rainmaker and oversaw all aspects of client relationship management and delivery, across a broad portfolio of consulting services. Karl was formerly Vice President, Corporate Development, Partnerships at Welltok, Inc., a digital health company revolutionizing the way population health managers align consumer actions and behaviors with the right incentives and rewards. In his role with Welltok, Mr. Hess was charged with identifying, exploring, cultivating, developing, managing and commercializing external partnership relations across more than 70 digital health categories for Welltok's CaféWell Connect Partner Program in support of the Connect Marketplace. Karl was previously a market and business development leader at WellDoc, Inc., a healthcare technology company with a mission to improve the lives of people with type 2 diabetes, by integrating clinical, behavioral, and motivational applications with everyday technologies to engage patients and healthcare providers in ways that dramatically improve outcomes and significantly reduce healthcare costs. Prior to WellDoc, Mr. Hess was a management consultant at PRTM, one of the world's foremost operational strategy management consulting firms, now a wholly-owned subsidiary of PwC Consulting. Earlier in his career, Karl worked for several start-up and Fortune 500 molecular diagnostics, biopharmaceutical, and medical technology companies including Genentech and Becton Dickinson, principally across market and business development. Karl began his career as a life sciences researcher, conducting pre-clinical cancer research at The University of Texas Southwestern Medical Center, and biotech R&D for what are now several subsidiaries of Thermo Fisher Scientific, Inc.
Executive level healthcare strategist skilled in: defining and implementing a vision to solve complex problems. This is accomplished by identifying/building relationships and establishing formal governance structures to create a safe space for dialogue, learning and evolution. Key leadership attributes: high energy, compassionate, analytical, and courageous. Currently serving as executive in residence for Denver University analytic program. Previously served as vice president of enterprise intelligence for Catholic Health Initiatives. Key leader in defining and implementing an analytics and data strategy – which is critical to CHI’s transition from a 3.5B holding company into a $15B healthcare delivery operating company. Consistently produced and promoted; identified as top talent needed to achieve CHI mission (create healthy communities).
Having managed her own chronic disease her whole life with her loving family and her pediatrician, Julia felt the incredible benefits of 24/7 compassionate care. Together with health experts and coaches from Stanford, Harvard and artificial intelligence technologists, they developed Lark- a 24/7 personal A.I. nurse that texts with people to help them manage and prevent chronic disease – anytime, anywhere.
Lark’s A.I. nurse is the first non-human technology to fully replace a live healthcare professional and be fully reimbursable with a CPT code, and is managing the equivalent caseload of 20,833 full time healthcare professionals. Lark works with health plans and providers to provide infinitely scalable healthcare. Lark has been named "10 Most Innovative Apps in the World" alongside Uber, Airbnb, and Wechat, and "Most Innovative Digital Health Product of the Year" by Wall Street Analyst Forrester Research, and "Top 10 Apps of 2015" out of all 2 million apps by Apple ,.
A serial entrepreneur, Julia was named number one in “2015’s Top 10 Women in Tech to Watch” and “30 Under 30” by Inc. Magazine, “Top Woman Inventor” by Marie Claire Magazine. Prior to founding Lark Technologies, Julia ran global startup incubator Clean Tech Open, her own green buildings startup, and was an EIR at Stanford’s StartX. She received her Master’s and Bachelor's degrees from Stanford, and half an MBA from MIT before leaving to start Lark. Julia has advised President Obama, is a faculty member at Singularity University, on the board of the Diabetes Prevention Council, and speaks regularly on digital health, IoT, and innovation on CNN, NBC, Bloomberg, MIT, and more.
Blackford Middleton is the Chief Informatics and Innovation at Apervita, Inc. He is also an Instructor in the Harvard TH Chan School of Public Health in the Departments of Health Policy and Management, and Policy Translation and Leadership Development. Previously, he was a professor of Biomedical Informatics, and or of Medicine, at Stanford, Harvard, and Vanderbilt Universities, and he held executive leadership roles at MedicaLogic/ Medscape, Partners Healthcare System, and at Vanderbilt. Dr. Middleton’s work is focused on clinical informatics – the applied science surrounding strategy, design, implementation, and evaluation of clinical information systems in complex environments. Currently, he is Co-Chair of the AHRQ-funded Patient-centered Clinical Decision Support Learning Network.
Dominique Morgan-Solomon, MPH, currently enjoys working with health care delivery, device management and health care services organizations on their population health strategies and program implementation. Prior to consulting Dominique was the Chief Operating Officer of Steward Medical Group and Vice President of Population Health for Steward Health Care from February 2012 until October of 2015. Over those 3+ years Dominique was part of the leadership team driving performance in Steward’s ACO programs. As Vice President of Population Health, Dominique was responsible for the strategic planning and execution of its quality performance, clinical integration care management and population health programs in support of Steward’s risk based business. In the role of Chief Operating Officer, Dominique oversaw the operations and management of Steward’s 700+ multi-specialty employed provider group, leading the implementation of value based care at the provider level.
Dominique also serves as Subject Matter Expert on Population Health processes and tools and has provided expertise to Integrated Delivery Networks, Technology and Investment groups on Population Health and Value – based care. She is a sought after National Speaker for biopharma organizations like Merck Pharmaceuticals on chronic disease and Population Health. Dominique is an advisor to several successful health care ‘start-up’ and non- profit organizations in the areas of health delivery and health equity. In 2015 she was awarded “Young Healthcare Executive of the Year” for her leadership in this burgeoning field by the National Association of Health Service Executives (NAHSE).
Prashant Natarajan is Director of Innovation & Strategy at Oracle in the Health Sciences GBU where he is responsible for a product & solution portfolio covering population health, precision medicine, interoperability & advanced analytics. He is a recognized thought leader (#HIT100) and customer advisor on deep/machine learning, IoT, big+little data, and embedded analytics. He is passionate about helping organizations maximize their technology investments to improve patient care, provider satisfaction, personal wellness and health policy. Prashant is a popular keynote speaker and best-selling author on emerging technolgies and their applications in multiple vertical including health sciences, e-commerce, and manufacturing. His books on Big Data & Machine Learning (2017) & Business Intelligence (2012) are top sellers in the genre (www.BigDataCXO.com). He has also co-authored chapters on precision medicine, communications in technology enviromets, and is currently Lead Editor of "Demystifying AI for the Enterprise" (2018). Prashant serves as Industry Advisor for the CIAPM computer vision projects at UCSF and is on the Board of Advisors at Council for Affordable Health Coverage, Washington DC. He also reaches Applied Deep/Machine Learning and Artificial intelligence as Co-Faculty Instructor at Stanford University, Palo Alto, CA.
Dr. Palacholla has extensive training in Medicine, Public Health and Connected Health and has successfully contributed to design, implementation and rigorous evaluation of several connected health solutions. Dr. Palacholla’s goal of improving access to high quality equitable healthcare, promoting wellness, preventing diseases and limiting the complications of chronic diseases motivated her to exploit the ubiquity of modern technologies to find innovative means of engaging patients. Her research interests have been focused on health outcomes research, systematic literature reviews/ meta-analysis, study designing, and data analysis with a focus on building patient self-management; improving patient-physician communication and the efficiency of clinical workflow. She has designed several pilot studies including randomized controlled trials focused on personal health solutions, mobile phone applications, tele-monitoring programs in addition to analyzing datasets for these projects. Currently, she is a Post-Doctoral Research Fellow in the Data Science & Analytics team which is responsible for designing rigorous research methodologies to evaluate digital health interventions at Partners Connected Health.
Jennifer is a Senior Business Analyst for the Lehigh Valley Health Network’s Enterprise Analytics division. She has served as a clinical quality specialist for the networks large multi-specialty group before transitioning full time to the Epic Transformation Project in the role of a process coordinator.
Suzanne’s programmatic efforts in medical device cybersecurity extend beyond incident response to include increasing awareness, educating, outreach, partnering and coalition-building within the Healthcare and Public Health Sector (HPH) as well as fostering collaborations across other parts of government and the private sector.
Suzanne earned an MD from Albert Einstein College of Medicine of Yeshiva University in New York in 1988, trained in General Surgery and Burn Trauma at the New York Presbyterian Hospital - Weill Cornell Medical Center; an executive MBA from NYU Stern School of Business in 2012, and completed Cohort X of the National Preparedness Leadership Initiative – Harvard School of Public Health & Harvard Kennedy School of Government executive education in June 2013.
Sid focuses on the future direction for the healthcare industry across the areas of advanced technologies, emerging business models and sites of care delivery evolution. He is the Lead Analyst on the recent study, ‘Internet of Medical Things’ and ‘Smart Hospitals’. His past work includes research on topics such as ‘Vision 2025: Future of Healthcare’ and ‘Future of Diabetes Care Paradigms’. Sid is a graduate of the Johns Hopkins University’s MS Biotechnology program, and has over six years of healthcare experience spanning areas of market research, custom consulting as well as biological stem cells (wet lab) research. He is also an author of scientific research articles, and is invited by authors to contribute to their Forbes articles. He can be reached at siddharth.shah@frost.com or on Twitter @Sid_Healthcare.
Dave Skibinski is president, CEO and co-founder of SnapMD, a full-service telehealth technology innovator and solutions provider. With over 25 years in the healthcare industry, Dave has worked across every sales and service channel in the industry including children’s hospitals, cancer centers, teaching institutions, and government healthcare at the federal, state and local levels. Dave also brings a proven record of success in the enterprise software and Internet/e-commerce business sectors. His time in the healthcare industry spans the earliest days of capitation and risk sharing contracts to the formation of today’s Accountable Care Organizations.